1-6 of 6
Dexiang Gao
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and Efficacy of Tucatinib, Letrozole, and Palbociclib in Patients with Previously Treated HR+/HER2+ Breast Cancer

Elena Shagisultanova, William Gradishar, Ursa Brown-Glaberman, Pavani Chalasani, Andrew J. Brenner, Alison Stopeck, Hannah Parris, Dexiang Gao, Tessa McSpadden, Jose Mayordomo, Jennifer R. Diamond, Peter Kabos, Virginia F. Borges
Journal: Clinical Cancer Research
Clin Cancer Res OF1–OF10.
https://doi.org/10.1158/1078-0432.CCR-23-0117
Published: 14 July 2023
View article titled, Safety and Efficacy of Tucatinib, Letrozole, and Palbociclib in Patients with Previously Treated HR+/HER2+ Breast Cancer
Open the PDF for Safety and Efficacy of Tucatinib, Letrozole, and Palbociclib in Patients with Previously Treated HR+/HER2+ Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Targeting MDSC Differentiation Using ATRA: A Phase I/II Clinical Trial Combining Pembrolizumab and All-Trans Retinoic Acid for Metastatic Melanoma

Richard P. Tobin, Dasha T. Cogswell, Victoria M. Cates, Dana M. Davis, Jessica S.W. Borgers, Robert J. Van Gulick, Elizabeth Katsnelson, Kasey L. Couts, Kimberly R. Jordan, Dexiang Gao, Eduardo Davila, Theresa M. Medina, Karl D. Lewis, Rene Gonzalez, Ross W. McFarland, William A. Robinson, Martin D. McCarter
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (7): 1209–1219.
https://doi.org/10.1158/1078-0432.CCR-22-2495
Published: 03 April 2023
View article titled, Targeting MDSC Differentiation Using ATRA: A Phase I/II Clinical Trial Combining Pembrolizumab and All-Trans Retinoic Acid for Metastatic Melanoma
Open the PDF for Targeting MDSC Differentiation Using ATRA: A Phase I/II Clinical Trial Combining Pembrolizumab and All-Trans Retinoic Acid for Metastatic Melanoma in another window
Includes: Supplementary data
Journal Articles

Abstract B07: Potential clinical value of methylated microRNAs in saliva-liquid biopsy for surveillance of head and neck squamous cell carcinoma

Ling Lv, Steve Quattlebaum, Dexiang Gao, Yu Cao, Ben Milam, Francis Hall, Derek Smith, Elyse Handley, Sophia Bornstein, Neil Gross, John Song, Shi-Long Lu
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (11_Supplement): B07.
https://doi.org/10.1158/1557-3265.LiqBiop20-B07
Published: 01 June 2020
View article titled, Abstract B07: Potential clinical value of methylated microRNAs in saliva-liquid biopsy for surveillance of head and neck squamous cell carcinoma
Journal Articles

Assessing lung cancer risk in bronchial dysplasia by identification of prognostic gene expression profiles

Christopher D. Coldren, Michio Sugita, Dexiang Gao, York E. Miller, Daniel T. Merrick, Wilbur A. Franklin, Robert L. Keith, Fred R. Hirsch, Mark W. Geraci, Raphael A. Nemenoff
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (19_Supplement): B15.
https://doi.org/10.1158/DIAG-10-B15
Published: 15 August 2014
View article titled, Assessing lung cancer risk in bronchial dysplasia by identification of prognostic gene expression profiles
Journal Articles

FGFR1 mRNA and Protein Expression, not Gene Copy Number, Predict FGFR TKI Sensitivity across All Lung Cancer Histologies

Murry W. Wynes, Trista K. Hinz, Dexiang Gao, Michael Martini, Lindsay A. Marek, Kathryn E. Ware, Michael G. Edwards, Diana Böhm, Sven Perner, Barbara A. Helfrich, Rafal Dziadziuszko, Jacek Jassem, Szymon Wojtylak, Aleksandra Sejda, Joseph M. Gozgit, Paul A. Bunn, Jr, D. Ross Camidge, Aik-Choon Tan, Fred R. Hirsch, Lynn E. Heasley
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2014) 20 (12): 3299–3309.
https://doi.org/10.1158/1078-0432.CCR-13-3060
Published: 12 June 2014
View article titled, FGFR1 mRNA and Protein Expression, not Gene Copy Number, Predict FGFR TKI Sensitivity across All Lung Cancer Histologies
Open the PDF for FGFR1 mRNA and Protein Expression, not Gene Copy Number, Predict FGFR TKI Sensitivity across All Lung Cancer Histologies in another window
Includes: Supplementary data
Journal Articles

Gene Array and Fluorescence In situ Hybridization Biomarkers of Activity of Saracatinib (AZD0530), a Src Inhibitor, in a Preclinical Model of Colorectal Cancer

John J. Arcaroli, Basel M. Touban, Aik Choon Tan, Marileila Varella-Garcia, Rebecca W. Powell, S. Gail Eckhardt, Paul Elvin, Dexiang Gao, Wells A. Messersmith
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (16): 4165–4177.
https://doi.org/10.1158/1078-0432.CCR-10-0066
Published: 11 August 2010
View article titled, Gene Array and Fluorescence <em>In situ</em> Hybridization Biomarkers of Activity of Saracatinib (AZD0530), a Src Inhibitor, in a Preclinical Model of Colorectal Cancer
Open the PDF for Gene Array and Fluorescence <em>In situ</em> Hybridization Biomarkers of Activity of Saracatinib (AZD0530), a Src Inhibitor, in a Preclinical Model of Colorectal Cancer in another window